ArticleOral oncology2025

Pathologic responses and clinical outcomes with neoadjuvant doublet chemotherapy for newly diagnosed, surgically-resectable p16-positive oropharyngeal cancer.

Alisha R Pershad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.